Peden VH, Witzleben CL & Skelton MA (1971) Total parenteral nutrition. J Pediatr 78, 180–181.
Lindor KD, Fleming CR, Abrams A & Hirschkorn MA (1979) Liver function values in adults receiving total parenteral nutrition. JAMA 241, 2398–2400.
Clarke PJ, Ball MJ & Kettlewell MG (1991) Liver function tests in patients receiving parenteral nutrition. J Parenter Enteral Nutr 15, 54–59.
Quigley EM, Marsh MN, Shaffer JL & Markin RS (1993) Hepatobiliary complications of total parenteral nutrition. Gastroenterology 104, 286–301.
Wolfe BM, Walker BK, Shaul DB, Wong L & Ruebner BH (1988) Effect of total parenteral nutrition on hepatic histology. Arch Surg 123, 1084–1090.
Luman W & Shaffer JL (2002) Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 21, 337–343.
Salvino R, Ghanta R, Seidner DL, Mascha E, Xu Y & Steiger E (2006) Liver failure is uncommon in adults receiving long-term parenteral nutrition. J Parenter Enteral Nutr 30, 202–208.
Ito Y & Shils ME (1991) Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. J Parenter Enteral Nutr 15, 271–276.
Chan S, McCowen KC, Bistrian BR, Thibault A, Keane-Ellison M, Forse RA, Babineau T & Burke P (1999) Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 126, 28–34.
Cavicchi M, Beau P, Crenn P, Degott C & Messing B (2000) Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132, 525–532.
Sheldon GF, Peterson SR & Sanders R (1978) Hepatic dysfunction during hyperalimentation. Arch Surg 113, 504–508.
Watkins JB, Szczepanik P, Gould JB, Klein P & Lester R (1975) Bile salt metabolism in the human premature infant. Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital. Gastroenterology 69, 706–713.
Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH & Eitzman DV (1979) Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 64, 342–347.
Beath SV, Davies P, Papadopoulou A, Khan AR, Buick RG, Corkery JJ, Gornall P & Booth IW (1996) Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 31, 604–606.
Sondheimer JM, Asturias E & Cadnapaphornchai M (1998) Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 27, 131–137.
Nightingale JM (2003) Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 17, 907–929.
Reddy BS, MacFie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K & Snelling AM (2007) Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin Nutr 26, 208–215.
Pappo I, Bercovier H, Berry E, Gallilly R, Feigin E & Freund HR (1995) Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. J Parenter Enteral Nutr 19, 80–82.
Buchman AL, Iyer K & Fryer J (2006) Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 43, 9–19.
Langrehr JM, Reilly MJ, Banner B, Warty VJ, Lee KK & Schraut WH (1991) Hepatic steatosis due to total parenteral nutrition: the influence of short-gut syndrome, refeeding, and small bowel transplantation. J Surg Res 50, 335–343.
Lauro A, Zanfi C, Ercolani G et al. (2006) Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. Transplant Proc 38, 3620–3624.
Greenberg GR, Wolman SL, Christofides ND, Bloom SR & Jeejeebhoy KN (1981) Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology 80, 988–993.
Alpers DH (2002) Enteral feeding and gut atrophy. Curr Opin Clin Nutr Metab Care 5, 679–683.
Hernandez G, Velasco N, Wainstein C, Castillo L, Bugedo G, Maiz A, Lopez F, Guzman S & Vargas C (1999) Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care 14, 73–77.
Sedman PC, MacFie J, Palmer MD, Mitchell CJ & Sagar PM (1995) Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br J Surg 82, 1663–1667.
Cook GC & Hutt MS (1967) The liver after kwashiokor. Br Med J 3, 454–457.
Richardson TJ & Sgoutas D (1975) Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr 28, 258–263.
Vina J, Vento M, Garcia-Sala F, Puertes IR, Gasco E, Sastre J, Asensi M & Pallardo FV (1995) L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 61, 1067–1069.
Chawla RK, Berry CJ, Kutner MH & Rudman D (1985) Plasma concentrations of transsulfuration pathway products during nasoenteral and intravenous hyperalimentation of malnourished patients. Am J Clin Nutr 42, 577–584.
Bowyer BA, Fleming CR, Ilstrup D, Nelson J, Reek S & Burnes J (1986) Plasma carnitine levels in patients receiving home parenteral nutrition. Am J Clin Nutr 43, 85–91.
Moukarzel AA, Dahlstrom KA, Buchman AL & Ament ME (1992) Carnitine status of children receiving long-term total parenteral nutrition: a longitudinal prospective study. J Pediatr 120, 759–762.
Buchman AL (2003) Choline deficiency during parenteral nutrition in humans. Nutr Clin Pract 18, 353–358.
Vinton NE, Laidlaw SA, Ament ME & Kopple JD (1987) Taurine concentrations in plasma, blood cells, and urine of children undergoing long-term total parenteral nutrition. Pediatr Res 21, 399–403.
Vinton NE, Laidlaw SA, Ament ME & Kopple JD (1986) Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition. Am J Clin Nutr 44, 398–404.
Karpati G, Carpenter S, Engel AG, Watters G, Allen J, Rothman S, Klassen G & Mamer OA (1975) The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology 25, 16–24.
Berner YN, Larchian WA, Lowry SF, Nicroa RR, Brennan MF & Shike M (1990) Low plasma carnitine in patients on prolonged total parenteral nutrition: association with low plasma lysine. J Parenter Enteral Nutr 14, 255–258.
Bowyer BA, Miles JM, Haymond MW & Fleming CR (1988) L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations. Gastroenterology 94, 434–438.
Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K & Ament ME (1993) Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr 12, 33–37.
Buchman AL, Sohel M, Moukarzel A et al. (2001) Plasma choline in normal newborns, infants, toddlers, and in very-low-birth-weight neonates requiring total parenteral nutrition. Nutrition 17, 18–21.
Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME & Eckhert CD (1992) Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 102, 1363–1370.
Buchman AL, Ament ME, Sohel M, Dubin M, Jenden DJ, Roch M, Pownall H, Farley W, Awal M & Ahn C (2001) Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J Parenter Enteral Nutr 25, 260–268.
Belli DC, Roy CC, Fournier LA, Tuchweber B, Giguere R & Yousef IM (1991) The effect of taurine on the cholestatic potential of sulfated lithocholate and its conjugates. Liver 11, 162–169.
Dorvil NP, Yousef IM, Tuchweber B & Roy CC (1983) Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin Nutr 37, 221–232.
Cooper A, Betts JM, Pereira GR & Ziegler MM (1984) Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition. J Pediatr Surg 19, 462–466.
Heird WC, Dell RB, Helms RA, Greene HL, Ament ME, Karna P & Storm MC (1987) Amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children requiring parenteral nutrition. Pediatrics 80, 401–408.
Spencer AU, Yu S, Tracy TF et al. (2005) Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. J Parenter Enteral Nutr 29, 337–343.
Schneider SM, Joly F, Gehrardt MF, Badran AM, Myara A, Thuillier F, Coudray-Lucas C, Cynober L, Trivin F & Messing B (2006) Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study. Br J Nutr 96, 365–370.
Hong L, Wu J & Cai W (2007) Glutathione decreased parenteral nutrition-induced hepatocyte injury in infant rabbits. J Parenter Enteral Nutr 31, 199–204.
Schepens MA, Roelofs HM, Peters WH & Wanten GJ (2006) No evidence for oxidative stress in patients on home parenteral nutrition. Clin Nutr 25, 939–948.
Lavoie JC, Chessex P, Gauthier C, Levy E, Alvarez F, St-Louis P & Rouleau T (2005) Reduced bile flow associated with parenteral nutrition is independent of oxidant load and parenteral multivitamins. J Pediatr Gastroenterol Nutr 41, 108–114.
Burke JF, Wolfe RR, Mullany CJ, Mathews DE & Bier DM (1979) Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake. Ann Surg 190, 274–285.
Li S, Nussbaum MS, Teague D, Gapen CL, Dayal R & Fischer JE (1988) Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res 44, 639–648.
Hwang TL, Lue MC & Chen LL (2000) Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogastroenterology 47, 1347–1350.
Guglielmi FW, Boggio-Bertinet D, Federico A et al. (2006) Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis 38, 623–642.
Li SJ, Nussbaum MS, McFadden DW, Gapen CL, Dayal R & Fischer JE (1988) Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats. Surgery 104, 350–357.
Meguid MM, Akahoshi MP, Jeffers S, Hayashi RJ & Hammond WG (1984) Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study. Arch Surg 119, 1294–1298.
Bigorgne C, Le Tourneau A, Messing B, Rio B, Giraud V, Molina T, Audouin J & Diebold J (1996) Sea-blue histiocyte syndrome in bone marrow secondary to total parenteral nutrition including fat-emulsion sources: a clinicopathologic study of seven cases. Br J Haematol 95, 258–262.
Clayton PT, Whitfield P & Iyer K (1998) The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 14, 158–164.
Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M & Milla PJ (1993) Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 105, 1806–1813.
Carpentier YA, Richelle M, Haumont D & Deckelbaum RJ (1990) New developments in fat emulsions. Proc Nutr Soc 49, 375–380.
Reimund JM, Arondel Y, Joly F, Messing B, Duclos B & Baumann R (2004) Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease. Clin Nutr 23, 1418–1425.
Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR & Puder M (2006) Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 118, e197–e201.
Vileisis RA, Inwood RJ & Hunt CE (1980) Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr 96, 893–897.
Klein GL (1991) The aluminum content of parenteral solutions: current status. Nutr Rev 49, 74–79.
Fell JM, Reynolds AP, Meadows N, Khan K, Long SG, Quaghebeur G, Taylor WJ & Milla PJ (1996) Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347, 1218–1221.
Blaszyk H, Wild PJ, Oliveira A, Kelly DG & Burgart LJ (2005) Hepatic copper in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 39, 318–320.
Kennedy JF & Nightingale JM (2005) Cost savings of an adult hospital nutrition support team. Nutrition 21, 1127–1133.
Beath SV, Booth IW, Murphy MS, Buckels JA, Mayer AD, McKiernan PJ & Kelly DA (1995) Nutritional care and candidates for small bowel transplantation. Arch Dis Child 73, 348–350.
Spurr SG, Grylack LJ & Mehta NR (1989) Hyperalimentation-associated neonatal cholestasis: effect of oral gentamicin. J Parenter Enteral Nutr 13, 633–636.
Kubota A, Okada A, Imura K, Kawahara H, Nezu R, Kamata S & Takagi Y (1990) The effect of metronidazole on TPN-associated liver dysfunction in neonates. J Pediatr Surg 25, 618–621.
Capron JP, Gineston JL, Herve MA & Braillon A (1983) Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet i, 446–447.
Messing B, Bories C, Kunstlinger F & Bernier JJ (1983) Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 84, 1012–1019.
Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR & Bartram CI (1992) Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 33, 1493–1497.
Buchman AL, Scolapio JS & Fryer JP (2003) American Gastroenterological Association technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 124, 1111–1134.
National Institute for Health and Clinical Excellence (2006) Nutrition Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. NICE Clinical Guideline 32. London: NICE.
Wallis K, Lloyd DA & Gabe SM (2007) Promoting intestinal adaptation. Br J Hosp Med 68, 11–14.
Food and Agriculture Organization/World Health Organization/United Nations University (1993) Fats and Oils in Human Nutrition. Report of a Joint Expert Consultation. FAO Food and Nutrition Paper no. 57. Geneva: WHO.
Chan S, McCowen KC & Bistrian B (1998) Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition. Curr Opin Clin Nutr Metab Care 1, 163–169.
Vahedi K, Atlan P, Joly F, Le Brun A, Evard D, Perennec V, Roux-Haguenau D, Bereziat G & Messing B (2005) A 3-month double-blind randomised study comparing an olive oil- with a soyabean oil-based intravenous lipid emulsion in home parenteral nutrition patients. Br J Nutr 94, 909–916.
Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS & Chang MH (2004) Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J Pediatr 145, 317–321.
De Marco G, Sordino D, Bruzzese E, Di Caro S, Mambretti D, Tramontano A, Colombo C, Simoni P & Guarino A (2006) Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther 24, 387–394.
Levine A, Maayan A, Shamir R, Dinari G, Sulkes J & Sirotta L (1999) Parenteral nutrition-associated cholestasis in preterm neonates: Evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 12, 549–553.
Spagnuolo MI, Iorio R, Vegnente A & Guarino A (1996) Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 111, 716–719.
Beau P, Labat-Labourdette J, Ingrand P & Beauchant M (1994) Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 20, 240–244.
Howard L & Ashley C (2003) Management of complications in patients receiving home parenteral nutrition. Gastroenterology 124, 1651–1661.
Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J & Ament ME (1995) Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 22, 1399–1403.
Misra S, Ahn C, Ament ME, Choi HJ, Jenden DJ, Roch M & Buchman AL (1999) Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study. J Parenter Enteral Nutr 23, 305–308.
Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, Goulet O & Farmer D (2005) 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 241, 607–613.
Middleton SJ & Jamieson NV (2005) The current status of small bowel transplantation in the UK and internationally. Gut 54, 1650–1657.